1.
Díaz C, Zapata C. Profound molecular response with ponatinib in chronic phase of chronic myeloid leukemia with resistance to imatinib and dasatinib: Case report and review of the literature. Rev Méd Hered [Internet]. 2022 Jul. 6 [cited 2024 May 6];33(2):133-8. Available from: https://revistas.upch.edu.pe/index.php/RMH/article/view/4247